SHIFT AI Newsroom · GLOBAL

Study Examines Glycaemic Changes After Semaglutide Discontinuation in Type 1 Diabetes

Researchers analysed the effects of stopping semaglutide in adults with type 1 diabetes using automated insulin delivery

Published 2026-09-10 · Evidence level 2

A recent study published in Europe PMC examined the glycaemic changes after semaglutide discontinuation in adults with type 1 diabetes using automated insulin delivery. The research provides valuable insights into the effects of stopping semaglutide on blood sugar control.

What this means in the UK

The study's findings may inform treatment decisions for UK patients with type 1 diabetes

Known facts

  • The ADJUST-T1D Extension Study analysed glycaemic changes after semaglutide discontinuation in adults with type 1 diabetes using automated insulin delivery

Sources and evidence

← Back to SHIFT AI Newsroom